PR-Section 8

VELIVET

Barr Laboratories, Inc.

Declaration of Use and/or Excusable Nonuse of Mark in Commerce under Section 8

PTO Form 1553 (Rev 5/2006)
OMB No. 0651-0055 (Exp 12/31/2011)

Declaration of Use and/or Excusable Nonuse of Mark in Commerce under Section 8


The table below presents the data as entered.

Input Field
Entered
REGISTRATION NUMBER 2977968
REGISTRATION DATE 07/26/2005
SERIAL NUMBER 76573827
MARK SECTION
MARK VELIVET
CORRESPONDENCE SECTION (current)
NAME TRACY-GENE G. DURKIN
FIRM NAME STERNE, KESSLER, GOLDSTEIN
STREET 1100 NEW YORK AVENUE, N.W.
CITY WASHINGTON
STATE District of Columbia
POSTAL CODE 20005-3934
COUNTRY United States
PHONE (202) 772-8660
FAX 202.371.2540
EMAIL TDURKIN@SKGF.COM
CORRESPONDENCE SECTION (proposed)
NAME Herschel Perel
FIRM NAME Teva Pharmaceuticals USA
INTERNAL ADDRESS Trademarks Department
STREET 425 Privet Road
CITY Horsham
STATE Pennsylvania
POSTAL CODE 19044
COUNTRY United States
PHONE 215-293-6406
FAX 215-293-6499
EMAIL herschel.perel@tevausa.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
DOCKET/REFERENCE NUMBER 2977968
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
GOODS OR SERVICES Pharmaceuticals, namely, oral contraceptives and pharmaceuticals for hormone replacement therapy
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN0-681771705-100417342_._USA_Velivet.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT11\IMAGEOUT11\765\738\76573827\xml5\S080002.JPG
SPECIMEN DESCRIPTION product label that has the name of the product printed on it.
MISCELLANEOUS STATEMENT Free text not entered by the applicant.
       ORIGINAL PDF FILE MISC-681771705-100417342_._USA_Velivet.pdf
        \\TICRS\EXPORT11\IMAGEOUT 11\765\738\76573827\xml5\ S080003.JPG
OWNER SECTION (current)
NAME Barr Laboratories, Inc.
STREET 2 Quaker Road
CITY Pomona
STATE New York
ZIP/POSTAL CODE 10970
COUNTRY United States
OWNER SECTION (proposed)
NAME Barr Laboratories, Inc.
STREET 400 Chestnut Ridge Road
CITY Woodcliff Lake
STATE New Jersey
ZIP/POSTAL CODE 07677
COUNTRY United States
PHONE 215-293-6406
FAX 215-293-6499
EMAIL XXXX
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
LEGAL ENTITY SECTION (current)
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
PAYMENT SECTION
NUMBER OF CLASSES 1
NUMBER OF CLASSES PAID 1
SUBTOTAL AMOUNT 100
TOTAL FEE PAID 100
SIGNATURE SECTION
SIGNATURE /herschel perel/
SIGNATORY'S NAME Herschel Perel
SIGNATORY'S POSITION Senior Director, Global Trademarks
DATE SIGNED 06/23/2011
PAYMENT METHOD DA
FILING INFORMATION
SUBMIT DATE Thu Jun 23 10:17:08 EDT 2011
TEAS STAMP USPTO/SECT08-XX.XXX.XXX.X
-20110623101708590698-297
7968-48089b76549a9486ea64
d2fee1238967998-DA-9145-2
0110623100417342220



PTO Form 1553 (Rev 5/2006)
OMB No. 0651-0055 (Exp 12/31/2011)


Declaration of Use and/or Excusable Nonuse of Mark in Commerce under Section 8


To the Commissioner for Trademarks:

REGISTRATION NUMBER: 2977968
REGISTRATION DATE: 07/26/2005

MARK: VELIVET

The owner, Barr Laboratories, Inc., a corporation of Delaware, having an address of
      400 Chestnut Ridge Road
      Woodcliff Lake, New Jersey 07677
      United States
is filing a Declaration of Use and/or Excusable Nonuse of Mark in Commerce under Section 8.

For International Class 005, the mark is in use in commerce on or in connection with all goods or services listed in the existing registration for this specific class: Pharmaceuticals, namely, oral contraceptives and pharmaceuticals for hormone replacement therapy ; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one specimen showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) product label that has the name of the product printed on it..

Original PDF file:
SPN0-681771705-100417342_._USA_Velivet.pdf
Converted PDF file(s) (1 page)
Specimen File1

MISCELLANEOUS STATEMENTS
Free text not entered by the applicant.

Original PDF file:
MISC-681771705-100417342_._USA_Velivet.pdf
Converted PDF file(s) (1 page)
Miscellaneous File1
The registrant's current Correspondence Information: TRACY-GENE G. DURKIN of  STERNE, KESSLER, GOLDSTEIN
      1100 NEW YORK AVENUE, N.W.
      WASHINGTON, District of Columbia (DC) 20005-3934
      United States (USX)

The registrant's proposed Correspondence Information: Herschel Perel of  Teva Pharmaceuticals USA
      Trademarks Department
      425 Privet Road
      Horsham, Pennsylvania (PA) 19044
      United States (USX)
The docket/reference number is 2977968.

The phone number is 215-293-6406.

The fax number is 215-293-6499.

The email address is herschel.perel@tevausa.com.

A fee payment in the amount of $100 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.

Declaration


Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods and/or services identified above, as evidenced by the attached specimen(s) showing the mark as used in commerce.

The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /herschel perel/      Date: 06/23/2011
Signatory's Name: Herschel Perel
Signatory's Position: Senior Director, Global Trademarks

Serial Number: 76573827
Internet Transmission Date: Thu Jun 23 10:17:08 EDT 2011
TEAS Stamp: USPTO/SECT08-XX.XXX.XXX.X-20110623101708
590698-2977968-48089b76549a9486ea64d2fee
1238967998-DA-9145-20110623100417342220

PR-Section 8 [image/jpeg]

PR-Section 8 [image/jpeg]

PR-Section 8 [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed